Atlas Trials

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation

Clinical trial NCT05031026 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05031026
Sponsor
Assiut University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Transplant; Complications
Start date
2022-03-15
Primary completion
2025-12-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.